|
2025-02-12 |
2025-02-11 |
S
Sale
|
HERSHBERG ROBERT
See Remarks
Executive Director
|
11,901
-1.1%
1.76
USD 21,003
|
11,901
-1.1%
|
1.76
|
USD 21,003
|
|
|
2025-02-12 |
2025-02-11 |
S
Sale
|
Maltbie Shane
Chief Financial Officer
Officer
|
4,345
-5.2%
1.76
USD 7,659
|
4,345
-5.2%
|
1.76
|
USD 7,659
|
|
|
2025-02-12 |
2025-02-04 |
S
Sale
|
HERSHBERG ROBERT
See Remarks
Executive Director
|
14,634
-1.3%
1.89
USD 27,658
|
14,634
-1.3%
|
1.89
|
USD 27,658
|
|
|
2025-02-12 |
2025-02-04 |
S
Sale
|
Maltbie Shane
Chief Financial Officer
Officer
|
3,946
-4.5%
1.89
USD 7,458
|
3,946
-4.5%
|
1.89
|
USD 7,458
|
|
|
2024-05-22 |
2024-05-22 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.8%
14.73
USD 88,372
|
6,000
-0.8%
|
14.73
|
USD 88,372
|
|
|
2024-05-22 |
2024-05-21 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.8%
14.21
USD 85,230
|
6,000
-0.8%
|
14.21
|
USD 85,230
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.8%
15.45
USD 92,689
|
6,000
-0.8%
|
15.45
|
USD 92,689
|
|
|
2024-05-03 |
2024-05-03 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
723
-0.1%
14.15
USD 10,233
|
723
-0.1%
|
14.15
|
USD 10,233
|
|
|
2024-05-03 |
2024-05-02 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.8%
14.01
USD 84,081
|
6,000
-0.8%
|
14.01
|
USD 84,081
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
175
-0.0%
14.03
USD 2,456
|
175
-0.0%
|
14.03
|
USD 2,456
|
|
|
2024-04-05 |
2024-04-05 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.8%
14.44
USD 86,640
|
6,000
-0.8%
|
14.44
|
USD 86,640
|
|
|
2024-04-08 |
2024-04-04 |
B
Purchase
|
Frazier Life Sciences X, L.P.
Large shareholder
|
8,850
+0.1%
14.50
USD 128,325
|
8,850
+0.1%
|
14.50
|
USD 128,325
|
|
|
2024-04-05 |
2024-04-04 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
14.71
USD 88,245
|
6,000
-0.7%
|
14.71
|
USD 88,245
|
|
|
2024-04-05 |
2024-04-03 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
14.93
USD 89,582
|
6,000
-0.7%
|
14.93
|
USD 89,582
|
|
|
2024-04-01 |
2024-03-28 |
B
Purchase
|
McLoughlin Sean
Chief Operating Officer
Officer
|
1,250
+inf%
16.98
USD 21,225
|
1,250
+inf%
|
16.98
|
USD 21,225
|
|
|
2024-03-20 |
2024-03-20 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
164,221.00
USD 985,326,000
|
6,000
-0.7%
|
164,221.00
|
USD 985,326,000
|
|
|
2024-03-20 |
2024-03-19 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
17.42
USD 104,492
|
6,000
-0.7%
|
17.42
|
USD 104,492
|
|
|
2024-03-20 |
2024-03-18 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
17.66
USD 105,937
|
6,000
-0.7%
|
17.66
|
USD 105,937
|
|
|
2024-03-08 |
2024-03-08 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
18.66
USD 111,959
|
6,000
-0.7%
|
18.66
|
USD 111,959
|
|
|
2024-03-08 |
2024-03-07 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
18.37
USD 110,213
|
6,000
-0.7%
|
18.37
|
USD 110,213
|
|
|
2024-03-08 |
2024-03-06 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
18.95
USD 113,701
|
6,000
-0.7%
|
18.95
|
USD 113,701
|
|
|
2024-02-22 |
2024-02-22 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
15.05
USD 90,312
|
6,000
-0.7%
|
15.05
|
USD 90,312
|
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
14.92
USD 89,495
|
6,000
-0.7%
|
14.92
|
USD 89,495
|
|
|
2024-02-22 |
2024-02-20 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
14.88
USD 89,272
|
6,000
-0.7%
|
14.88
|
USD 89,272
|
|
|
2024-02-14 |
2024-02-12 |
PS
Planned sale
|
Kohli Aditya
Non-Executive Director
|
6,000
-0.7%
15.32
USD 91,921
|
6,000
-0.7%
|
15.32
|
USD 91,921
|
|
|
2024-02-12 |
2024-02-08 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
3,933
-2.4%
14.93
USD 58,726
|
3,933
-2.4%
|
14.93
|
USD 58,726
|
|
|
2024-02-12 |
2024-02-08 |
S
Sale
|
HERSHBERG ROBERT
See Remarks
Executive Director
|
11,597
-1.2%
14.93
USD 173,161
|
11,597
-1.2%
|
14.93
|
USD 173,161
|
|
|
2024-02-12 |
2024-02-08 |
S
Sale
|
Kohli Aditya
Non-Executive Director
|
8,866
-1.1%
14.93
USD 132,383
|
8,866
-1.1%
|
14.93
|
USD 132,383
|
|
|
2024-02-12 |
2024-02-08 |
S
Sale
|
Maltbie Shane
Chief Financial Officer
Officer
|
3,576
-8.1%
14.93
USD 53,395
|
3,576
-8.1%
|
14.93
|
USD 53,395
|
|
|
2023-12-18 |
2023-12-15 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
10,000
-5.7%
15.50
USD 155,000
|
10,000
-5.7%
|
15.50
|
USD 155,000
|
|
|
2023-12-05 |
2023-12-04 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
10,000
-5.4%
14.50
USD 145,000
|
10,000
-5.4%
|
14.50
|
USD 145,000
|
|
|
2023-12-05 |
2023-12-01 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
10,000
-5.1%
14.20
USD 142,000
|
10,000
-5.1%
|
14.20
|
USD 142,000
|
|
|
2023-11-20 |
2023-11-17 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
10,000
-4.9%
14.00
USD 140,000
|
10,000
-4.9%
|
14.00
|
USD 140,000
|
|
|
2023-11-13 |
2023-11-08 |
S
Sale
|
Borkowski Astrid
Chief Medical Officer
Officer
|
5,000
-2.4%
13.00
USD 65,000
|
5,000
-2.4%
|
13.00
|
USD 65,000
|
|
|
2022-05-03 |
2022-05-03 |
B
Purchase
|
Frazier Life Sciences X, L.P.
Large shareholder
|
1,764,706
+26.1%
17.00
USD 30,000,002
|
1,764,706
+26.1%
|
17.00
|
USD 30,000,002
|
|
